Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
6
×
drugs
6
×
life sciences
national blog main
boston
clinical trials
fda
alnylam pharmaceuticals
national top stories
new york blog main
new york top stories
aminolevulinic acid
givosiran
onpattro
patisiran
rna interference
san diego blog main
san diego top stories
accelerated approval
acute hepatic porphyria
acute hepatic porphyrias
akcea therapeutics
akin akinc
aldehyde
aldeyra therapeutics
allergic conjunctivitis
allopregnanolone
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brexanolone
cancer
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
dry eye disease
entrectinib
european medicines agency
What
drug
6
×
medicine
6
×
fda
new
alnylam
interference
rna
rnai
second
approved
data
oks
pharmaceuticals
seek
speedy
ago
aldeyra
approval
approves
brexanolone
cancer
cells
cleared
closer
deeper
depression
devastating
disclosed
disorder
dna
ema
employ
europe
eye
far
fast
fighting
filing
fingerprint
follows
Language
Current search:
drugs
×
medicine
×
drug
×
" boston top stories "
×
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug